Abstract
The enhanced-sensitivity Trofile assay (TF-ES; Monogram Biosciences) was used to retest coreceptor tropism samples from 4 different cohorts of HIV-1-infected patients. Nine percent to 26% of patients with CCR5-tropic virus by the original Trofile assay had CXCR4-using virus by TF-ES. Lower CD4 cell counts were associated with CXCR4-using virus in all cohorts.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 925-928 |
| Number of pages | 4 |
| Journal | Clinical Infectious Diseases |
| Volume | 52 |
| Issue number | 7 |
| DOIs | |
| State | Published - Apr 1 2011 |
Bibliographical note
Funding Information:Financial Support. The CPCRA and INSIGHT networks are funded by the National Institutes of Health (U01 AI-42170, U01 AI-46362, U01 AI-68641). The ACTG is funded by the National Institutes of Health (U01 AI-68636 and AI-68634 [Statistical and Data Analysis Center]). Other grants that funded coauthors include K23 AI55038 (to T.J.W.), K24 AI51966 (to R.M.G.), AI-69419 (Cornell Clinical Trials Unit), RR024996 (Cornell CTSC), and AI-46381 (Miriam Hospital Clinical Research Site). Monogram Biosciences received an SBIR grant from the National Institutes of Health (R44AI050321).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS